[
  {
    "publisher": [
      ""
    ],
    "title": [
      "Page xii: The agency warned pregnant women"
    ],
    "type": "book"
  },
  {
    "container-title": [
      "Dow Jones Newswires, article",
      "New York Times"
    ],
    "date": [
      "2003",
      "2003-11-04"
    ],
    "issue": [
      ""
    ],
    "title": [
      "The ultrasound and cell phone stories have been reported in numerous publications. The information about blood banks came from the story “Panel Calls for West Nile Tests on All U.S.-Stored Blood",
      "and the information about China is from Joseph Kahn, “Foul Water and Air Part of Cost of the Boom in China’s Exports"
    ],
    "type": "article-journal",
    "volume": [
      "19",
      "A1"
    ]
  },
  {
    "publisher": [
      ""
    ],
    "title": [
      "Page xii: New York Times claimed the new warnings"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Harris",
        "given": "Gardiner"
      }
    ],
    "container-title": [
      "New York Times"
    ],
    "date": [
      "2004-03-23"
    ],
    "title": [
      "Regulators Want Antidepressants to List Warnings"
    ],
    "type": "article-journal",
    "volume": [
      "A1"
    ]
  },
  {
    "author": [
      {
        "family": "xiii",
        "given": "Page"
      }
    ],
    "pages": [],
    "title": [
      "You don’t just ask someone to clam up"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Mathews",
        "given": "Anna Wilde"
      }
    ],
    "container-title": [
      "Wall Street Journal"
    ],
    "date": [
      "2004-05-25"
    ],
    "pages": [
      "1"
    ],
    "title": [
      "In Debate Over Antidepressants, FDA Weighed Risk of False Alarm"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "xiii",
        "given": "Page"
      },
      {
        "literal": ". . [Gardiner Harris"
      }
    ],
    "container-title": [
      "New York Times"
    ],
    "date": [
      "2004-09-14"
    ],
    "pages": [
      "1"
    ],
    "title": [
      "Temple admitted that all the clinical trials",
      "FDA Links Drugs to Being Suicidal"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Schmidt",
        "given": "Dr Alexander M."
      }
    ],
    "container-title": [
      "Carpenter, “The Political Economy of FDA Drug Review,” Health Affairs"
    ],
    "date": [
      "2004-01"
    ],
    "pages": [
      "54"
    ],
    "title": [
      "Page 28: Famously, a former commissioner",
      "There are many references to this speech, which is also attributed to testimony that Schmidt gave to Congress; the citation I used came from Daniel P"
    ],
    "type": "article-journal"
  },
  {
    "publisher": [
      ""
    ],
    "title": [
      "Page 29: Drugs with the FDA’s imprimatur kill"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Mathews",
        "given": "Anna Wilde"
      }
    ],
    "container-title": [
      "the Government Accountability Office ( formerly the General Accounting Office",
      "Wall Street Journal"
    ],
    "date": [
      "2004-10-04"
    ],
    "issue": [
      ""
    ],
    "pages": [],
    "title": [
      "Vioxx Recall Raises Questions of FDA’s Safety Monitoring"
    ],
    "type": "article-journal",
    "volume": [
      "B1"
    ]
  },
  {
    "author": [
      {
        "family": "Plan",
        "given": "Strategic Action"
      }
    ],
    "container-title": [
      "published by the FDA"
    ],
    "date": [
      "2003-08"
    ],
    "pages": [
      "28"
    ],
    "title": [
      "Food and Drug Administration"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "literal": "."
      }
    ],
    "date": [
      "2001"
    ],
    "location": [
      "Page 35"
    ],
    "note": [
      ". . [Upton Sinclair, The Jungle, Signet Classic,"
    ],
    "pages": [
      "102"
    ],
    "publisher": [
      ""
    ],
    "title": [
      ". as for the other men, who worked in tank rooms full of steam"
    ],
    "type": null
  },
  {
    "container-title": [],
    "date": [
      "1982"
    ],
    "pages": [
      "32"
    ],
    "publisher": [
      "Paul Starr, The Social Transformation of American Medicine, Basic Books"
    ],
    "title": [
      "Page 36: Some Colonial doctors published manuals"
    ],
    "type": "chapter"
  },
  {
    "date": [
      "1991"
    ],
    "pages": [
      "82–83"
    ],
    "publisher": [
      "Mark Twain, Tom Sawyer, Vintage Books"
    ],
    "title": [
      "Page 36: In Tom Sawyer, written from 1874 to 1875"
    ],
    "type": "book",
    "volume": []
  },
  {
    "container-title": [
      "Hilts, in his history of the FDA"
    ],
    "pages": [],
    "title": [
      "Page 37: Philip J"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "family": "Hilts",
        "given": "Philip J."
      }
    ],
    "date": [
      "2003"
    ],
    "location": [
      "Page 37"
    ],
    "note": [
      "As the FDA itself points out . . ."
    ],
    "pages": [
      "22"
    ],
    "publisher": [
      "Knopf"
    ],
    "title": [
      "Protecting America’s Health: The FDA, Business, and One Hundred Years of Regulation, Alfred A"
    ],
    "type": null
  },
  {
    "author": [
      {
        "literal": "“Milestones in U.S. Food and Drug Law History,” which I accessed on the FDA"
      },
      {
        "literal": ". . [Philip J. Hilts"
      }
    ],
    "date": [
      "2003"
    ],
    "location": [
      "Page 39"
    ],
    "note": [
      "The results—severe indigestion, stomach pain . . . [Ibid., 40."
    ],
    "pages": [
      "11, 15"
    ],
    "publisher": [
      "Wiley was",
      "Knopf"
    ],
    "title": [
      "Web site at http://www.cfsan.fda.gov/mileston.html.] Page 39: As Philip Hilts describes him",
      "Protecting America’s Health: The FDA, Business, and One Hundred Years of Regulation, Alfred A"
    ],
    "type": null
  },
  {
    "container-title": [
      "Larrick . . . Ibid"
    ],
    "pages": [
      "142"
    ],
    "title": [
      "Page 43: Nor did the feeble FDA under then Commissioner George P"
    ],
    "type": "article-journal",
    "volume": [
      "137–138"
    ]
  },
  {
    "publisher": [
      ""
    ],
    "title": [
      "Page 49: The FDA’s acting commissioner admitted to"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Walsh",
        "given": "Katherine"
      },
      {
        "family": "Waldholz",
        "given": "Michael"
      }
    ],
    "container-title": [
      "Wall Street Journal"
    ],
    "date": [
      "1990-02-27"
    ],
    "issue": [
      ""
    ],
    "location": [
      "Page 49"
    ],
    "note": [
      "Later that year TPA was approved . . ."
    ],
    "title": [
      "U.S. to Continue Probing Pfizer’s Troubled Valve—FDA Chief Admits Agency Had Dealt Improperly with Defective Device"
    ],
    "type": "article-journal",
    "volume": [
      "A3"
    ]
  },
  {
    "author": [
      {
        "family": "Hall",
        "given": "Stephen S."
      }
    ],
    "date": [
      "2003"
    ],
    "pages": [
      "15"
    ],
    "publisher": [
      "Houghton-Mifflin Co"
    ],
    "title": [
      "Merchants of Immortality: Chasing the Dream of Human Life Extension"
    ],
    "type": "book"
  },
  {
    "publisher": [
      ""
    ],
    "title": [
      "Page 51: Several FDA initiatives to give consumers"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Hilts",
        "given": "Philip J."
      }
    ],
    "date": [
      "2003"
    ],
    "pages": [
      "215–217"
    ],
    "publisher": [
      "Knopf"
    ],
    "title": [
      "Protecting America’s Health: The FDA, Business, and One Hundred Years of Regulation, Alfred A"
    ],
    "type": "book"
  },
  {
    "publisher": [
      ""
    ],
    "title": [
      "Page 52: In his 1994 book The FDA Follies"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Burkholz",
        "given": "Herbert"
      }
    ],
    "date": [
      "1994"
    ],
    "pages": [
      "117–122"
    ],
    "publisher": [
      "Basic Books"
    ],
    "title": [
      "The FDA Follies"
    ],
    "type": "book"
  },
  {
    "publisher": [
      ""
    ],
    "title": [
      "Page 72: David Kessler in his book called Cooper"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Kessler",
        "given": "David"
      }
    ],
    "container-title": [
      "Public Affairs"
    ],
    "date": [
      "2001"
    ],
    "note": [
      "Page 74: Two-thirds of all the land. . ."
    ],
    "pages": [
      "175"
    ],
    "title": [
      "A Question of Intent: A Great American Battle with a Deadly Industry"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Thurow",
        "given": "Roger"
      },
      {
        "family": "Kilman",
        "given": "Scott"
      },
      {
        "family": "White",
        "given": "Gregory L."
      }
    ],
    "container-title": [
      "Wall Street Journal"
    ],
    "date": [
      "2004-06-18"
    ],
    "pages": [
      "1"
    ],
    "title": [
      "New Farm Powers Sow the Seeds of America’s Agricultural Woes"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "literal": "Dr. Henry I. Miller, a former FDA official . . . [Henry I. Miller"
      }
    ],
    "date": [
      "2000"
    ],
    "genre": [
      "Page 89:"
    ],
    "location": [
      "Page 91"
    ],
    "note": [
      "Novartis had to change the name . . ."
    ],
    "pages": [
      "65–66"
    ],
    "publisher": [
      "Hoover Institution Press"
    ],
    "title": [
      "To America’s Health"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Vasella",
        "given": "Daniel"
      }
    ],
    "date": [
      "2003"
    ],
    "pages": [
      "151–153"
    ],
    "publisher": [
      "HarperBusiness"
    ],
    "title": [
      "Magic Cancer Bullet"
    ],
    "type": "book"
  },
  {
    "publisher": [
      ""
    ],
    "title": [
      "Page 95: “A fully paginated document"
    ],
    "type": "book"
  },
  {
    "container-title": [
      "February"
    ],
    "date": [
      "2000"
    ],
    "pages": [
      "7"
    ],
    "title": [
      "“Guidance for Industry: Formal Meetings with Sponsors and Applicants for PDUFA Products,” published by the FDA, Center for Drug Evaluation and Research and Center for Biologics Evaluation and Research"
    ],
    "type": "article-journal"
  },
  {
    "location": [
      "Page 116"
    ],
    "publisher": [
      "",
      ""
    ],
    "title": [
      ". multiple myeloma is the second-most common"
    ],
    "type": "book"
  },
  {
    "date": [
      "1997"
    ],
    "pages": [
      "779 891"
    ],
    "publisher": [
      "Merck & Co"
    ],
    "title": [
      "The data on multiple myeloma and also leprosy come from a variety of sources, including Celgene, the American Cancer Society, and The Merck Manual of Medical Information"
    ],
    "type": "book"
  },
  {
    "publisher": [
      ""
    ],
    "title": [
      "Page 117: For instance, the newspaper chain reported"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Young",
        "given": "Alison"
      },
      {
        "family": "Adams",
        "given": "Chris"
      }
    ],
    "container-title": [
      "St. Paul Pioneer Press"
    ],
    "date": [
      "2003-11-02"
    ],
    "publisher": [
      ""
    ],
    "title": [
      "Off-label Use Growing",
      "Page 118: For years the medical community"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Abboud",
        "given": "Leila"
      }
    ],
    "container-title": [
      "Wall Street Journal"
    ],
    "date": [
      "2004-08-03"
    ],
    "pages": [
      "1"
    ],
    "title": [
      "Off-Label Treatments, New Drugs Target Mysterious, Debilitating Fibromyalgia"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "literal": ". . [Andrew Pollack"
      }
    ],
    "container-title": [
      "New York Times"
    ],
    "date": [
      "2004-05-12"
    ],
    "note": [
      "The information about Neurontin has been widely reported."
    ],
    "pages": [
      "1"
    ],
    "title": [
      "Page 120: A one-time sales rep for a small California biotech",
      "Suit by Former Employee Charges Promotion of Drug’s Off-Label Use"
    ],
    "type": "article-journal"
  },
  {
    "publisher": [
      ""
    ],
    "title": [
      "Page 129: BusinessWeek in February 2002 described"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Arnst",
        "given": "Catherine"
      }
    ],
    "container-title": [
      "138: DiMasi came up with his total",
      "BusinessWeek"
    ],
    "date": [
      "2002-02-18"
    ],
    "location": [
      "Page"
    ],
    "pages": [
      "68"
    ],
    "title": [
      "Where ImClone Went Wrong"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Hawthorne",
        "given": "Fran"
      }
    ],
    "pages": [
      "64"
    ],
    "publisher": [
      "John Wiley & Sons"
    ],
    "title": [
      "The Merck Druggernaut"
    ],
    "type": "book"
  },
  {
    "container-title": [
      "138: In 2004, Pfizer made eyes pop"
    ],
    "location": [
      "Page"
    ],
    "pages": [
      "65–66"
    ],
    "title": [
      "Page 138: Using an entirely different system"
    ],
    "type": "chapter",
    "volume": [
      "Ibid"
    ]
  },
  {
    "author": [
      {
        "family": "Hensley",
        "given": "Scott"
      },
      {
        "family": "Winslow",
        "given": "Ron"
      }
    ],
    "container-title": [
      "Wall Street Journal"
    ],
    "date": [
      "2004-04-08"
    ],
    "pages": [
      "67–68"
    ],
    "publisher": [
      "Fran Hawthorne, The Merck Druggernaut, John Wiley & Sons"
    ],
    "title": [
      "Pfizer Makes $800 Million Bid to Reshape Heart-Care Market",
      "A1.] Page 139: Consumer groups, meanwhile, tended"
    ],
    "type": "article-journal"
  },
  {
    "publisher": [
      ""
    ],
    "title": [
      "Page 147: There was, in fact, an explicit concern"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Temple",
        "given": "Robert"
      }
    ],
    "container-title": [
      "Governmental Regulation of Drugs"
    ],
    "date": [
      "1995"
    ],
    "pages": [
      "1646"
    ],
    "title": [
      "Development of Drug Law, Regulations, and Guidance in the United States"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "given": "reported"
      }
    ],
    "container-title": [
      "The Wall Street Journal in",
      "Wall Street Journal"
    ],
    "date": [
      "2004-07",
      "2004-07-09"
    ],
    "note": [
      "In a paper published in the American Journal of Political Science . . ."
    ],
    "title": [
      "Page 149",
      "After Medtronic Lobbying Push, the FDA Had Change of Heart",
      "A1.] Page 157"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Carpenter",
        "given": "Daniel P."
      }
    ],
    "container-title": [
      "NOTES 321 Page 158: Nine years earlier, in 1994",
      "American Journal of Political Science"
    ],
    "date": [
      "2002-07"
    ],
    "pages": [
      "490–505"
    ],
    "title": [
      "Groups, the Media, Agency Waiting Costs, and FDA Drug Approval"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Dranove",
        "given": "David"
      },
      {
        "family": "Meltzer",
        "given": "David"
      }
    ],
    "container-title": [
      "RAND Journal of Economics"
    ],
    "date": [
      "1994"
    ],
    "pages": [
      "402–423"
    ],
    "title": [
      "Do Important Drugs Reach the Market Sooner?"
    ],
    "type": "article-journal"
  },
  {
    "publisher": [
      ""
    ],
    "title": [
      "Page 159: When the consumer group Public Citizen"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Lurie",
        "given": "Peter"
      },
      {
        "family": "Wolfe",
        "given": "Sidney M."
      }
    ],
    "container-title": [
      "Public Citizen"
    ],
    "date": [
      "1998-12-02"
    ],
    "note": [
      "Page 162: Daniel Carpenter of Harvard has studied . . ."
    ],
    "title": [
      "FDA Medical Officers Report Lower Standards Permit Dangerous Drug Approvals"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Carpenter",
        "given": "Daniel P."
      },
      {
        "family": "Turenne",
        "given": "Marc"
      }
    ],
    "container-title": [
      "Harvard-MIT Workshop on Positive Political Economy"
    ],
    "date": [
      "2001-03-16"
    ],
    "note": [
      "In fact, critics charged that during . . ."
    ],
    "title": [
      "Why Do Bigger Firms Receive Faster Drug Approvals?",
      "Page 165"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "family": "Stolberg",
        "given": "Sheryl Gay"
      }
    ],
    "container-title": [
      "New York Times"
    ],
    "date": [
      "2003-07-25"
    ],
    "publisher": [
      "Office"
    ],
    "title": [
      "FDA Officials Press Legislators to Oppose Bill on Importing Less Expensive Drugs",
      "Page 166: The small staff in the FDA’s"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Tesoriero",
        "given": "Heather Won"
      }
    ],
    "container-title": [
      "Wall Street Journal"
    ],
    "date": [
      "2004"
    ],
    "note": [
      "an estimated 3.5 percent . . ."
    ],
    "title": [
      "Fake-Drug Sites Keep a Step Ahead",
      "D4.] Page 167: Moreover"
    ],
    "type": "article-journal",
    "volume": [
      "August 10"
    ]
  },
  {
    "author": [
      {
        "family": "Kissel",
        "given": "Mary"
      }
    ],
    "container-title": [
      "Wall Street Journal"
    ],
    "date": [
      "2004-07-07"
    ],
    "note": [
      "Sixty-two percent of the people polled . . ."
    ],
    "title": [
      "Labeling Rules Likely for Food Allergies",
      "D1.] Page 167"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Zernike",
        "given": "Kate"
      }
    ],
    "container-title": [
      "New York Times"
    ],
    "date": [
      "2003-11-09"
    ],
    "title": [
      "Is Obesity the Responsibility of the Body Politic?"
    ],
    "type": "article-journal"
  },
  {
    "publisher": [
      ""
    ],
    "title": [
      "Page 169: In 2001 the FDA and the food industry"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Ellison",
        "given": "Sarah"
      }
    ],
    "container-title": [
      "Wall Street Journal"
    ],
    "date": [
      "2004-07-25"
    ],
    "pages": [
      "1"
    ],
    "title": [
      "Blood Sugar, Sugar Alcohol and the FDA"
    ],
    "type": "article-journal"
  },
  {
    "date": [
      "2003"
    ],
    "location": [
      "Page 175"
    ],
    "note": [
      ". [Ibid., 170."
    ],
    "pages": [
      "117"
    ],
    "publisher": [
      "Peter Pringle, Food, Inc., Simon & Schuster",
      "As the journalist Peter Pringle"
    ],
    "title": [
      "Page 174: Britain’s Prince Charles joined"
    ],
    "type": null
  },
  {
    "issue": [
      "ue . . "
    ],
    "title": [
      "Page 203: Writing in the January–February 2004"
    ],
    "type": null,
    "volume": []
  },
  {
    "author": [
      {
        "family": "Carpenter",
        "given": "Daniel P."
      }
    ],
    "container-title": [
      "Health Affairs"
    ],
    "date": [
      "2004-01"
    ],
    "pages": [
      "56–57"
    ],
    "title": [
      "The Political Economy of FDA Drug Review"
    ],
    "type": "article-journal"
  },
  {
    "date": [
      "2002-07"
    ],
    "title": [
      "Page 203: No wonder that in his"
    ],
    "type": null,
    "volume": []
  },
  {
    "author": [
      {
        "family": "Carpenter",
        "given": "Daniel P."
      }
    ],
    "container-title": [
      "American Journal of Political Science"
    ],
    "date": [
      "2002-07"
    ],
    "pages": [
      "490–505"
    ],
    "title": [
      "Groups, the Media, Agency Waiting Costs, and FDA Drug Approval"
    ],
    "type": "article-journal"
  },
  {
    "location": [
      "Page 204"
    ],
    "note": [
      ". . at one point in 2004 . . ."
    ],
    "publisher": [
      ""
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Grady",
        "given": "Denise"
      }
    ],
    "container-title": [
      "New York Times"
    ],
    "date": [
      "2004-07-26"
    ],
    "publisher": [
      ""
    ],
    "title": [
      "Heeding a Call to Test Breast Cancer Treatments",
      "A1.] Page 204: “By just about any measure"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Carpenter",
        "given": "Daniel P."
      }
    ],
    "container-title": [
      "Health Affairs"
    ],
    "date": [
      "2004-01"
    ],
    "pages": [
      "57"
    ],
    "title": [
      "The Political Economy of FDA Drug Review"
    ],
    "type": "article-journal"
  },
  {
    "container-title": [
      "American Journal of Political Science"
    ],
    "title": [
      "Page 205: In his"
    ],
    "type": "article-journal",
    "volume": []
  },
  {
    "author": [
      {
        "family": "Carpenter",
        "given": "Daniel P."
      }
    ],
    "container-title": [
      "American Journal of Political Science"
    ],
    "date": [
      "2002-07"
    ],
    "pages": [
      "500"
    ],
    "title": [
      "Groups, the Media, Agency Waiting Costs, and FDA Drug Approval"
    ],
    "type": "article-journal"
  },
  {
    "location": [
      "Page 212"
    ],
    "publisher": [
      "Mark McClellan and staffers"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Stolberg",
        "given": "Sheryl Gay"
      }
    ],
    "container-title": [
      "New York Times"
    ],
    "date": [
      "2003-07-25"
    ],
    "title": [
      "FDA Officials Press Legislators to Oppose Bill on Importing Less Expensive Drugs"
    ],
    "type": "article-journal"
  },
  {
    "publisher": [
      ""
    ],
    "title": [
      "Page 216: By contrast, months before he was named"
    ],
    "type": "book"
  },
  {
    "container-title": [
      "and a speech at the MedAdNews Pharmaceutical Leadership Forum, an industry conference",
      "October"
    ],
    "date": [
      "2003",
      "2003-11-17"
    ],
    "title": [
      "To give just two examples: The Fifth Annual David A. Winston Lecture at the National Press Club"
    ],
    "type": "article-journal",
    "volume": [
      "20"
    ]
  },
  {
    "publisher": [
      ""
    ],
    "title": [
      "Page 216: During the 2004 election"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Calmes",
        "given": "Jackie"
      },
      {
        "family": "John Harwood",
        "particle": "also"
      }
    ],
    "container-title": [
      "Wall Street Journal",
      "Wall Street Journal",
      "According to the Wall Street Journal"
    ],
    "date": [
      "2004-10-15",
      "2004-10-29"
    ],
    "note": [
      "he participated . . ."
    ],
    "title": [
      "Washington Wire",
      "Washington Wire",
      "A4.] Page 220"
    ],
    "type": "article-journal",
    "volume": [
      "A4"
    ]
  },
  {
    "author": [
      {
        "family": "Abboud",
        "given": "Leila"
      }
    ],
    "container-title": [
      "Wall Street Journal"
    ],
    "date": [
      "2004-06-18"
    ],
    "publisher": [
      ""
    ],
    "title": [
      "FDA Official Criticized Agency for Scrutiny of Contraceptive",
      "B4.] Page 223: Several groups of health professionals"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Navarro",
        "given": "Mireya"
      }
    ],
    "container-title": [
      "New York Times"
    ],
    "location": [
      "Page 223"
    ],
    "pages": [
      "2004"
    ],
    "publisher": [
      "The National Academy of Sciences even held an all-day"
    ],
    "title": [
      "Experts in Sex Field Say Conservatives Interfere with Health and Research"
    ],
    "type": "article-journal",
    "volume": [
      "July 10"
    ]
  },
  {
    "author": [
      {
        "family": "Brown",
        "given": "David"
      }
    ],
    "date": [
      "2004-07-22"
    ],
    "genre": [
      "Washington Post,"
    ],
    "note": [
      "Page 223: As the New York Times put it . . ."
    ],
    "title": [
      "Panel Debates Politics’ Role in Scientists’ Appointment"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Brinkley",
        "given": "Joel"
      }
    ],
    "container-title": [
      "New York Times"
    ],
    "date": [
      "2004-08-14"
    ],
    "issue": [
      ""
    ],
    "location": [
      "Page 225"
    ],
    "publisher": [
      "Even an executive from Bristol-Myers Squibb"
    ],
    "title": [
      "Out of Spotlight, Bush Overhauls U.S. Regulations"
    ],
    "type": "article-journal",
    "volume": [
      "A1"
    ]
  },
  {
    "author": [
      {
        "family": "Pollack",
        "given": "Andrew"
      }
    ],
    "container-title": [
      "New York Times"
    ],
    "date": [
      "2003-06-02"
    ],
    "pages": [
      "1"
    ],
    "title": [
      "New Tacks in Cancer Treatment Show Promise in 2 Clinical Trials"
    ],
    "type": "article-journal"
  },
  {
    "container-title": [],
    "date": [
      "1982"
    ],
    "pages": [
      "129–133"
    ],
    "publisher": [
      "Paul Starr, The Social Transformation of American Medicine, Basic Books"
    ],
    "title": [
      "Page 254: According to the writer Paul Starr in his book"
    ],
    "type": "chapter"
  },
  {
    "container-title": [
      "Page 261: In a study released in November 2001"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "family": "Drugs",
        "given": "Prescription"
      },
      {
        "family": "Advertising",
        "given": "Mass Media"
      }
    ],
    "date": [
      "2000"
    ],
    "publisher": [
      "National Institute for Health Care Management"
    ],
    "type": "book"
  },
  {
    "container-title": [
      ". . [“International Survey on Wellness and Consumer Reaction to DTC Advertising of Rx Drugs,” Prevention"
    ],
    "date": [
      "2000"
    ],
    "pages": [
      "52–55"
    ],
    "title": [
      "Page 263: When Prevention magazine queried 1,222 Americans"
    ],
    "type": "chapter"
  },
  {
    "publisher": [
      ""
    ],
    "title": [
      "Page 264: “Medicines aren’t like shampoo or perfume"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Marcus",
        "given": "Erin N."
      }
    ],
    "container-title": [
      "New York Times"
    ],
    "date": [
      "2003-01-03"
    ],
    "note": [
      "Page 270: “I was surprised how minor they were . . ."
    ],
    "title": [
      "When TV Commercials Play the Doctor"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Ehrlich",
        "given": "Robert"
      }
    ],
    "container-title": [
      "rxinsight.com, February 6"
    ],
    "date": [
      "2004"
    ],
    "title": [
      "A Little Evolution from the FDA"
    ],
    "type": "chapter"
  },
  {
    "publisher": [
      ""
    ],
    "title": [
      "Page 271: Even an industry insider like Bob Ehrlich"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Ehrlich",
        "given": "Robert"
      }
    ],
    "date": [
      "2003-09-12"
    ],
    "title": [
      "FDA Hearings: New DTC Action Coming?” rxinsight.com"
    ],
    "type": null
  },
  {
    "container-title": [],
    "date": [
      "1997"
    ],
    "pages": [
      "516"
    ],
    "publisher": [
      "The Merck Manual of Medical Information, Merck & Co"
    ],
    "title": [
      "Page 274: Derived from a toxin"
    ],
    "type": "chapter"
  },
  {
    "publisher": [
      ""
    ],
    "title": [
      "Pages 276/277: “Schering-Plough’s Clarinex illustrates"
    ],
    "type": "book"
  },
  {
    "date": [
      "2002-07"
    ],
    "location": [
      "Families USA"
    ],
    "pages": [
      "11"
    ],
    "title": [
      "“Profiting from Pain: Where Prescription Dollars Go"
    ],
    "type": null
  },
  {
    "publisher": [
      ""
    ],
    "title": [
      "Page 277: “We think most experts would agree"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Relman",
        "given": "Arnold S."
      },
      {
        "family": "Angell",
        "given": "Marcia"
      }
    ],
    "container-title": [
      "The New Republic"
    ],
    "date": [
      "2002-12-16"
    ],
    "pages": [
      "32"
    ],
    "title": [
      "America’s Other Drug Problem"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "literal": ". . . [Robert Temple and Susan S. Ellenberg"
      }
    ],
    "container-title": [
      "Annals of Internal Medicine"
    ],
    "date": [
      "2000",
      "2000-09-19"
    ],
    "location": [
      "Page 280"
    ],
    "note": [
      "To Marcia Angell, the former. . ."
    ],
    "pages": [
      "460"
    ],
    "title": [
      "Pages 278/279: As Bob Temple wrote in the September 19",
      "Placebo-Controlled Trials and Active-Control Trials in the Evaluation of New Treatments"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Jaret",
        "given": "Peter"
      }
    ],
    "container-title": [
      "Los Angeles Times"
    ],
    "date": [
      "2004-08-09"
    ],
    "publisher": [
      ""
    ],
    "title": [
      "She Turns Her Pen on Drug Makers",
      "F1.] Page 280: AstraZeneca also had 11 separate patents"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Relman",
        "given": "Arnold S."
      },
      {
        "family": "Angell",
        "given": "Marcia"
      }
    ],
    "container-title": [
      "The New Republic"
    ],
    "date": [
      "2002-12-16"
    ],
    "pages": [
      "38"
    ],
    "title": [
      "America’s Other Drug Problem"
    ],
    "type": "article-journal"
  },
  {
    "publisher": [
      ""
    ],
    "title": [
      "Page 281: In fact, when Bristol-Myers Squibb in 2000"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Harris",
        "given": "Gardiner"
      },
      {
        "family": "Adams",
        "given": "Chris"
      }
    ],
    "container-title": [
      "Wall Street Journal"
    ],
    "date": [
      "2001-07-12"
    ],
    "issue": [
      ""
    ],
    "title": [
      "Drug Manufacturers Step Up Legal Attacks That Slow Generics"
    ],
    "type": "article-journal",
    "volume": [
      "A1"
    ]
  },
  {
    "publisher": [
      ""
    ],
    "title": [
      "Page 289: When he and four other academics"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Neumann",
        "given": "Peter J."
      },
      {
        "family": "Bambauer",
        "given": "Kara Zivin"
      },
      {
        "family": "Ramakrishnan",
        "given": "Vijay"
      },
      {
        "family": "Stewart",
        "given": "Kate A."
      },
      {
        "family": "Bell",
        "given": "Chaim M."
      }
    ],
    "container-title": [
      "Medical Care"
    ],
    "date": [
      "2002"
    ],
    "pages": [
      "840–803"
    ],
    "title": [
      "Economic Messages in Prescription Drug Advertisements in Medical Journals"
    ],
    "type": "article-journal"
  },
  {
    "publisher": [
      ""
    ],
    "title": [
      "Page 299: But in the summer of 2003"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Armstrong",
        "given": "David"
      }
    ],
    "container-title": [
      "In a typical year",
      "Wall Street Journal"
    ],
    "date": [
      "2003-10-23"
    ],
    "pages": [],
    "title": [
      "How Drug Directory Helps Raise Tab for Medicaid and Insurers",
      "A1.] Page 304"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Mathews",
        "given": "Anna Wilde"
      }
    ],
    "container-title": [
      "Wall Street Journal"
    ],
    "date": [
      "2004-10-04"
    ],
    "publisher": [
      ""
    ],
    "title": [
      "Vioxx Recall Raises Questions of FDA’s Safety Monitoring",
      "B1.] Page 304: There was also growing concern that problems with devices"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Meier",
        "given": "Barry"
      }
    ],
    "container-title": [
      "New York Times"
    ],
    "date": [
      "2004-12-15"
    ],
    "issue": [
      ""
    ],
    "location": [
      "Page 306"
    ],
    "publisher": [
      "For his part, Spitzer first told"
    ],
    "title": [
      "Flawed Device Places FDA Under Scrutiny"
    ],
    "type": "article-journal",
    "volume": [
      "A1"
    ]
  },
  {
    "author": [
      {
        "family": "Harris",
        "given": "Gardiner"
      }
    ],
    "container-title": [
      "New York Times, June",
      "the Times"
    ],
    "date": [
      "2004"
    ],
    "title": [
      "Spitzer Sues a Drug Maker, Saying It Hid Negative Data",
      "A1.] Page 306: Two and a half months later"
    ],
    "type": "article-journal",
    "volume": [
      "3"
    ]
  },
  {
    "author": [
      {
        "family": "Harris",
        "given": "Gardiner"
      }
    ],
    "container-title": [
      "New York Times"
    ],
    "date": [
      "2004-08-27"
    ],
    "location": [
      "Bibliography"
    ],
    "pages": [
      "4"
    ],
    "title": [
      "Glaxo Agrees to Post Results of Drug Trials on Web Site"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Angell",
        "given": "Marcia"
      },
      {
        "given": "M.D."
      }
    ],
    "date": [
      "2004"
    ],
    "publisher": [
      "Random House"
    ],
    "title": [
      "The Truth About the Drug Companies: How They Deceive Us and What to Do About It"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Atwood",
        "given": "Margaret"
      }
    ],
    "date": [
      "2003"
    ],
    "publisher": [
      "Nan A. Talese/Doubleday"
    ],
    "title": [
      "Oryx and Crake"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Avorn",
        "given": "Jerry"
      },
      {
        "given": "M.D."
      }
    ],
    "date": [
      "2004"
    ],
    "publisher": [
      "Knopf"
    ],
    "title": [
      "Powerful Medicines: The Benefits, Risks, and Costs of Prescription Drugs"
    ],
    "type": "book"
  },
  {
    "container-title": [
      "The Merck Manual of Medical Information",
      "Merck Research Laboratories"
    ],
    "date": [
      "1997"
    ],
    "edition": [
      "home"
    ],
    "editor": [
      {
        "family": "Berkow",
        "given": "Robert"
      },
      {
        "given": "M.D."
      }
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Bovard",
        "given": "James"
      }
    ],
    "date": [
      "1994"
    ],
    "publisher": [
      "St. Martin’s Press"
    ],
    "title": [
      "Lost Rights: The Destruction of American Liberty"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Boyer",
        "given": "Paul"
      }
    ],
    "date": [
      "2001"
    ],
    "publisher": [
      "Holt Rinehart and Winston"
    ],
    "title": [
      "The American Nation"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Burkholz",
        "given": "Herbert"
      }
    ],
    "date": [
      "1994"
    ],
    "publisher": [
      "Basic Books"
    ],
    "title": [
      "The FDA Follies"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Byers",
        "given": "Michael"
      }
    ],
    "date": [
      "2003"
    ],
    "publisher": [
      "Houghton Mifflin Co"
    ],
    "title": [
      "Long for the World"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Cohen",
        "given": "Jay S."
      },
      {
        "given": "M.D."
      }
    ],
    "container-title": [
      "Jeremy P. Tarder/Putnam"
    ],
    "date": [
      "2001",
      "1997"
    ],
    "publisher": [
      "Compton’s Encyclopedia"
    ],
    "title": [
      "Over Dose: The Case Against the Drug Companies"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Crichton",
        "given": "Michael"
      }
    ],
    "date": [
      "1990"
    ],
    "publisher": [
      "Ballantine Books"
    ],
    "title": [
      "Jurassic Park"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Crichton",
        "given": "Michael"
      }
    ],
    "date": [
      "2002"
    ],
    "location": [
      "Avon Books"
    ],
    "title": [
      "Prey"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Critser",
        "given": "Greg"
      }
    ],
    "date": [
      "2003"
    ],
    "publisher": [
      "Mariner Books/Houghton Mifflin"
    ],
    "title": [
      "Fat Land: How Americans Became the Fattest People in the World"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Greider",
        "given": "Katharine"
      }
    ],
    "container-title": [
      "Public Affairs"
    ],
    "date": [
      "2003"
    ],
    "title": [
      "The Big Fix: How the Pharmaceutical Industry Rips Off American Consumers"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Griffinhagen",
        "given": "George"
      }
    ],
    "date": [
      "2002"
    ],
    "publisher": [
      "American Pharmaceutical Association"
    ],
    "title": [
      "150 Years of Caring"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Hall",
        "given": "Stephen S."
      }
    ],
    "date": [
      "2003"
    ],
    "publisher": [
      "Houghton Mifflin Co"
    ],
    "title": [
      "Merchants of Immortality: Chasing the Dream of Human Life Extension"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Hawthorne",
        "given": "Fran"
      }
    ],
    "date": [
      "2003"
    ],
    "publisher": [
      "John Wiley & Sons, Inc"
    ],
    "title": [
      "The Merck Druggernaut: The Inside Story of a Pharmaceutical Giant"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Hilts",
        "given": "Philip J."
      }
    ],
    "date": [
      "2003"
    ],
    "publisher": [
      "Alfred A. Knopf"
    ],
    "title": [
      "Protecting America’s Health: The FDA, Business, and One Hundred Years of Regulation"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Huxley",
        "given": "Aldous"
      }
    ],
    "date": [
      "1960"
    ],
    "publisher": [
      "HarperPerennial/Harper Collins"
    ],
    "title": [
      "Brave New World"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Kessler",
        "given": "David"
      }
    ],
    "container-title": [
      "Public Affairs"
    ],
    "date": [
      "2001"
    ],
    "title": [
      "A Question of Intent: A Great American Battle with a Deadly Industry"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Lieberman",
        "given": "Trudy"
      }
    ],
    "container-title": [
      "The New Press"
    ],
    "date": [
      "2000"
    ],
    "title": [
      "Slanting the Story: The Forces That Shape the News"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Miller",
        "given": "Henry I."
      },
      {
        "given": "M.D."
      }
    ],
    "date": [
      "2000"
    ],
    "publisher": [
      "Hoover Institution Press"
    ],
    "title": [
      "To America’s Health: A Proposal to Reform the Food and Drug Administration"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Ozeki",
        "given": "Ruth"
      }
    ],
    "date": [
      "2003"
    ],
    "publisher": [
      "Penguin Books"
    ],
    "title": [
      "All Over Creation"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Perlin",
        "given": "David"
      },
      {
        "family": "PhD."
      },
      {
        "family": "Cohen",
        "given": "Ann"
      }
    ],
    "date": [
      "2002"
    ],
    "publisher": [
      "Alpha"
    ],
    "title": [
      "Dangerous Diseases and Epidemics"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Pringle",
        "given": "Peter"
      }
    ],
    "date": [
      "2003"
    ],
    "publisher": [
      "Simon & Schuster"
    ],
    "title": [
      "Food, Inc.: Mendel to Monsanto—The Promises and Perils of the Biotech Harvest"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Schlosser",
        "given": "Eric"
      }
    ],
    "date": [
      "2002"
    ],
    "publisher": [
      "Perennial/ HarperCollins"
    ],
    "title": [
      "Fast Food Nation: The Dark Side of the All-American Meal"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Sinclair",
        "given": "Upton"
      }
    ],
    "date": [
      "2001"
    ],
    "publisher": [
      "Signet Classic"
    ],
    "title": [
      "The Jungle"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Smith",
        "given": "Ian"
      }
    ],
    "date": [
      "2004"
    ],
    "publisher": [
      "Doubleday"
    ],
    "title": [
      "The Blackbird Papers"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Starr",
        "given": "Paul"
      }
    ],
    "date": [
      "1982"
    ],
    "publisher": [
      "Basic Books"
    ],
    "title": [
      "The Social Transformation of American Medicine"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Teitelman",
        "given": "Robert"
      }
    ],
    "date": [
      "1989"
    ],
    "publisher": [
      "Basic Books"
    ],
    "title": [
      "Gene Dreams: Wall Street, Academia, and the Rise of Biotechnology"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Twain",
        "given": "Mark"
      }
    ],
    "date": [
      "1991"
    ],
    "publisher": [
      "Vintage Books"
    ],
    "title": [
      "Tom Sawyer"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Vasella",
        "given": "Daniel"
      },
      {
        "given": "M.D."
      }
    ],
    "date": [
      "2003"
    ],
    "publisher": [
      "HarperBusiness"
    ],
    "title": [
      "Magic Cancer Bullet: How a Tiny Orange Pill Is Rewriting Medical History"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "research",
        "particle": "my"
      }
    ],
    "title": [
      "I read hundreds of newspaper and magazine articles from a range of publications. This list highlights some of the most important, along with papers from academic journals and other reports"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Carpenter",
        "given": "Daniel P."
      }
    ],
    "container-title": [
      "American Journal of Political Science"
    ],
    "date": [
      "2002-07"
    ],
    "issue": [
      "3"
    ],
    "title": [
      "Groups, the Media, Agency Waiting Costs, and FDA Drug Approval"
    ],
    "type": "article-journal",
    "volume": [
      "46"
    ]
  },
  {
    "author": [
      {
        "family": "Carpenter",
        "given": "Daniel P."
      }
    ],
    "container-title": [
      "Health Affairs"
    ],
    "date": [
      "2004-01"
    ],
    "issue": [
      "1"
    ],
    "title": [
      "The Political Economy of FDA Drug Review"
    ],
    "type": "article-journal",
    "volume": [
      "23"
    ]
  },
  {
    "author": [
      {
        "family": "Carpenter",
        "given": "Daniel P."
      },
      {
        "family": "Turenne",
        "given": "Marc"
      }
    ],
    "container-title": [
      "Presentation at the Harvard-MIT Workshop on Positive Political Economy"
    ],
    "date": [
      "2001-03-16"
    ],
    "title": [
      "Why Do Bigger Firms Receive Faster Drug Approvals?"
    ],
    "type": "chapter"
  },
  {
    "container-title": [
      "Nutrition Action Health Letter"
    ],
    "date": [
      "2001-06",
      "2001-11"
    ],
    "issue": [
      "9"
    ],
    "note": [
      "Center for Science in the Public Interest. “Outbreak Alert! Closing the Gaps in Our Federal Food-Safety Net” (September 2002)."
    ],
    "title": [
      "Center for Science in the Public Interest. “Death on the Half Shell: The Failure of Regulators and the Shellfish Industry to Prevent Deaths and Illnesses from Gulf Coast Shellfish",
      "Center for Science in the Public Interest. “Genetically Engineered Foods: Are They Safe?"
    ],
    "type": "article-journal",
    "volume": [
      "28"
    ]
  },
  {
    "author": [
      {
        "family": "Dahl",
        "given": "Elizabeth"
      },
      {
        "family": "DeWaal",
        "given": "Caroline Smith"
      }
    ],
    "container-title": [
      "Center for Science in the Public Interest"
    ],
    "date": [
      "1997-05"
    ],
    "title": [
      "Scrambled Eggs: How a Broken Food Safety System Let Contaminated Eggs Become a National Food Poisoning Epidemic"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Danzon",
        "given": "Patricia"
      },
      {
        "family": "Furukawa",
        "given": "Michael"
      },
      {
        "family": "DiMasi",
        "given": "Joseph A."
      },
      {
        "family": "DiMasi",
        "given": "Joseph A."
      },
      {
        "family": "Hansen",
        "given": "Ronald W."
      },
      {
        "family": "Grabowski",
        "given": "Henry G."
      },
      {
        "family": "Lasagna",
        "given": "Louis"
      }
    ],
    "container-title": [
      "Health Affairs",
      "Clinical Pharmacology & Therapeutics (May",
      "Pharmaceutical Industry.” Pharmacoeconomics"
    ],
    "date": [
      "2003-10",
      "1995-02"
    ],
    "title": [
      "Prices and Availability of Pharmaceuticals: Evidence from Nine Countries",
      "Risks in New Drug Development: Approval Success Rates for Investigational Drugs",
      "Research and Development Costs for New Drugs by Therapeutic Category: A Study of the U.S"
    ],
    "type": "article-journal",
    "volume": [
      "2001"
    ]
  },
  {
    "author": [
      {
        "family": "Dranove",
        "given": "David"
      },
      {
        "family": "Meltzer",
        "given": "David"
      }
    ],
    "container-title": [
      "RAND Journal of Economics"
    ],
    "date": [
      "1994"
    ],
    "issue": [
      "3"
    ],
    "title": [
      "Do Important Drugs Reach the Market Sooner?"
    ],
    "type": "article-journal",
    "volume": [
      "25"
    ]
  },
  {
    "author": [
      {
        "family": "Families",
        "given": "U.S.A."
      },
      {
        "family": "Fenichel",
        "given": "Robert R."
      },
      {
        "family": "Oparil",
        "given": "Suzanne"
      },
      {
        "family": "Weber",
        "given": "Michael A."
      },
      {
        "family": "Zorab",
        "given": "Richard"
      },
      {
        "family": "Saunders",
        "given": "W.B."
      }
    ],
    "container-title": [
      "from Hypertension: A Companion to Brenner & Rector’s The Kidney"
    ],
    "date": [
      "2002",
      "2000",
      "1997"
    ],
    "editor": [
      {
        "literal": "eds."
      }
    ],
    "location": [
      "Confronting AIDS"
    ],
    "publisher": [
      "Science and Business Cross a Unique Frontier.” Merck & Co"
    ],
    "title": [
      "Profiting from Pain: Where Prescription Drug Dollars Go",
      "How Hypertensive Drugs Get Approved in the U.S",
      "Galambos, Louis"
    ],
    "translator": [
      {
        "family": "Sewell",
        "given": "Jane Eliot"
      }
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "family": "Garvey",
        "given": "Thomas"
      },
      {
        "family": "Hoffman",
        "given": "Freddie Ann"
      }
    ],
    "container-title": [
      "Presentation at the Second Pan-American Conference on Drug Regulatory Harmonization"
    ],
    "date": [
      "November 3–4, 1999"
    ],
    "title": [
      "Food, Cosmetic, and Medical Product Classification in the United States"
    ],
    "type": "paper-conference"
  },
  {
    "author": [
      {
        "family": "Hubbard",
        "given": "Tim"
      },
      {
        "family": "Love",
        "given": "James"
      }
    ],
    "container-title": [
      "PloS Biology"
    ],
    "date": [
      "2004-02"
    ],
    "issue": [
      "2"
    ],
    "title": [
      "A New Trade Framework for Global Healthcare R&D"
    ],
    "type": "article-journal",
    "volume": [
      "2"
    ]
  },
  {
    "author": [
      {
        "family": "Kazman",
        "given": "Sam"
      }
    ],
    "container-title": [
      "Journal of Regulation & Social Costs"
    ],
    "date": [
      "1990-09"
    ],
    "issue": [
      "1"
    ],
    "title": [
      "Deadly Overcaution"
    ],
    "type": "article-journal",
    "volume": [
      "1"
    ]
  },
  {
    "author": [
      {
        "family": "Kazman",
        "given": "Sam"
      }
    ],
    "container-title": [
      "Journal of Regulation & Social Costs"
    ],
    "date": [
      "1992-06"
    ],
    "title": [
      "Saying Yes to Drugs"
    ],
    "type": "article-journal",
    "volume": [
      "2"
    ]
  },
  {
    "author": [
      {
        "family": "Kessler",
        "given": "David A."
      },
      {
        "family": "Mande",
        "given": "Jerold R."
      },
      {
        "family": "Scarbrough",
        "given": "F.Edward"
      },
      {
        "family": "Schapiro",
        "given": "Renie"
      },
      {
        "family": "Feiden",
        "given": "Karyn"
      }
    ],
    "container-title": [
      "Harvard Health Policy Review"
    ],
    "date": [
      "2003"
    ],
    "issue": [
      "2"
    ],
    "title": [
      "Developing the ‘Nutrition Facts’ Food Label"
    ],
    "type": "article-journal",
    "volume": [
      "4"
    ]
  },
  {
    "author": [
      {
        "family": "Lurie",
        "given": "Peter"
      },
      {
        "family": "Wolfe",
        "given": "Sidney M."
      }
    ],
    "container-title": [
      "Public Citizen"
    ],
    "date": [
      "1998-12-02"
    ],
    "title": [
      "FDA Medical Officers Report Lower Standards Permit Dangerous Drug Approvals"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Milne",
        "given": "Christopher-Paul"
      }
    ],
    "container-title": [
      "Tufts Center for the Study of Drug Development"
    ],
    "date": [
      "2001-04"
    ],
    "title": [
      "The Pediatric Studies Incentive: Equal Medicines for All"
    ],
    "type": "chapter"
  },
  {
    "date": [
      "2000-08"
    ],
    "title": [
      "National Institute for Health Care Management. “Prescription Drugs and Intellectual Property Protection"
    ],
    "type": null
  },
  {
    "date": [
      "2001-11"
    ],
    "title": [
      "National Institute for Health Care Management. “Prescription Drugs and Mass Media Advertising"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Neumann",
        "given": "Peter J."
      },
      {
        "family": "Bambauer",
        "given": "Kara Zivin"
      },
      {
        "family": "Ramakrishnan",
        "given": "Vijay"
      },
      {
        "family": "Stewart",
        "given": "Kate A."
      },
      {
        "family": "Bell",
        "given": "Chaim M."
      }
    ],
    "container-title": [
      "Medical Care"
    ],
    "date": [
      "2002"
    ],
    "issue": [
      "9"
    ],
    "title": [
      "Economic Messages in Prescription Drug Advertisements in Medical Journals"
    ],
    "type": "article-journal",
    "volume": [
      "40"
    ]
  },
  {
    "author": [
      {
        "family": "Neumann",
        "given": "Peter J."
      },
      {
        "family": "Claxton",
        "given": "Karl"
      },
      {
        "family": "Weinstein",
        "given": "Milton C."
      }
    ],
    "container-title": [
      "Health Affairs"
    ],
    "date": [
      "2000-09"
    ],
    "issue": [
      "5"
    ],
    "title": [
      "The FDA’s Regulation of Health Economic Information"
    ],
    "type": "article-journal",
    "volume": [
      "19"
    ]
  },
  {
    "author": [
      {
        "family": "Noguchi",
        "given": "Philip D."
      }
    ],
    "container-title": [
      "Food and Drug Law Journal"
    ],
    "date": [
      "1996"
    ],
    "title": [
      "From Jim to Gene and Beyond: An Odyssey of Biologics Regulation"
    ],
    "type": "article-journal",
    "volume": [
      "51"
    ]
  },
  {
    "author": [
      {
        "family": "Peltz",
        "given": "Michael"
      }
    ],
    "container-title": [
      "Bloomberg Markets"
    ],
    "date": [
      "2004-01-05"
    ],
    "title": [
      "Antigenics’s Cancer Drug Gives Its Shareholders Indigestion"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Bioethics",
        "given": "President’s Council",
        "particle": "on"
      }
    ],
    "date": [
      "2003-10"
    ],
    "title": [
      "Beyond Therapy: Biotechnology and the Pursuit of Happiness"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Relman",
        "given": "Arnold S."
      },
      {
        "family": "Angell",
        "given": "Marcia"
      }
    ],
    "container-title": [
      "The New Republic"
    ],
    "date": [
      "2002-12-16"
    ],
    "title": [
      "America’s Other Drug Problem"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Schumacher",
        "given": "Martha"
      }
    ],
    "date": [
      "2000"
    ],
    "editor": [
      {
        "family": "Slaughter",
        "given": "Ed"
      }
    ],
    "genre": [
      "Prevention"
    ],
    "title": [
      "International Survey on Wellness and Consumer Reaction to DTC Advertising of Rx Drugs"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Stewart",
        "given": "Kate A."
      },
      {
        "family": "Neumann",
        "given": "Peter J."
      }
    ],
    "container-title": [
      "Value in Health"
    ],
    "date": [
      "2002"
    ],
    "issue": [
      "5"
    ],
    "title": [
      "FDA Actions against Misleading or Unsubstantiated Economic and Quality-of-Life Promotional Claims"
    ],
    "type": "article-journal",
    "volume": [
      "5"
    ]
  },
  {
    "author": [
      {
        "family": "Temple",
        "given": "Robert"
      },
      {
        "family": "Willman",
        "given": "David"
      }
    ],
    "container-title": [
      "Communications in Statistics",
      "Los Angeles Times"
    ],
    "date": [
      "1995",
      "1994",
      "2000-12-20"
    ],
    "title": [
      "Development of Drug Law, Regulations, and Guidance in the United States,” from Governmental Regulation of Drugs",
      "Temple, Robert. “Special Study Designs: Early Escape, Enrichment, Studies in Non-Responders",
      "How a New Policy Led to Seven Deadly Drugs"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Wood",
        "given": "Alastair J.J."
      },
      {
        "family": "Stein",
        "given": "C.Michael"
      },
      {
        "family": "Woosley",
        "given": "Raymond"
      }
    ],
    "container-title": [
      "The New England Journal of Medicine"
    ],
    "date": [
      "1998-12-17"
    ],
    "issue": [
      "25"
    ],
    "title": [
      "Making Medicines Safer—The Need for an Independent Drug Safety Board",
      "Index"
    ],
    "type": "article-journal",
    "volume": [
      "339"
    ]
  },
  {
    "author": [
      {
        "family": "Fox",
        "given": "Michael J."
      }
    ],
    "container-title": [
      "Michael",
      "Steve",
      "See Scandals and Garvey, Dr. Thomas Q"
    ],
    "date": [
      "1958",
      "1906",
      "1938"
    ],
    "issue": [
      "CDER"
    ],
    "note": [
      "jurisdiction. See Jurisdiction Frivolous drugs, 273–284, 291–295 move to new quarters planned in 2010, FTC (Federal Trade Commission), 66,",
      "scope of, 23–26 Genentech, Inc., 49 staff of, 30–31 Generic drugs, 46, 50–51, 283–284 steps to moving a drug from lab to market, 8 Genetically modified food and animals, 68–69, terrorism and,",
      "248–250 Type I mistakes, 27–29, 80–81, 202–204 Genzyme, 9, 12 Type II mistakes, 27–29, 44, 80–81, 202–204 George, Donna, 179–181, 189 FDA Follies, The, 52 George, Monica, 179–189, 268"
    ],
    "pages": [
      "236",
      "40–41",
      "41–63",
      "271",
      "130–131,",
      "240–241, 123–142 244–245,",
      "299–300",
      "96–98,",
      "137–138,",
      "233",
      "301–303 172–176,",
      "23–24"
    ],
    "title": [
      "FDA eggs, 65–66 advertising and. See Advertising and the FDA fish, 67–68, 248 Center for Biologics Evaluation and food regulation prior to FDA, 37 Research (CBER), 23–24, 67, 106, 130, genetically modified, 68–69, 172–176, 226–231, 233–242, 251 248–250 Center for Devices and Radiological Health meat, agencies responsible for, 68 (CDRH), 23, 67 milk, 175 Center for Drug Evaluation and research obesity, 169",
      "oysters, 171–172 Center for Food Safety and Applied pet food industry, 166–167 Nutrition (CFSAN), 23, 67, 132 restaurants, 69–70, 167–168 Center for Veterinary Medicine (CVM), 23, terrorist acts and food supply, 302–303 67, 75, 248 Food Additives Amendment",
      "48 consumer anger against, 191–207 Food and Drug Act",
      "food and drug regulation prior to, 35–40 Food and Drug Administration (FDA). frivolous drugs and, 273–284 See FDA future challenges. See Future challenges Food, Drug, and Cosmetics Act",
      "42, for FDA 44, 116 generic drugs, 46, 50–51, 283–284 Foreman, Carol Tucker, 170 history of",
      "205 industry complaints about, 126–138 Friedman, Dr",
      "70 241–242 Future challenges for FDA, 285–308 new drug approval time, 26 cost of medicine, 285–291 Office of Cellular, Tissue, and Gene destructive living habits, 295–299 Therapies, 3 drug information database, 303–307 paperwork. See Paperwork terrorism, 300–303 as political pawn. See Politics and the FDA tobacco, 299–300 positive public perception of, 25 vanity or frivolous drugs, 291–295 relations to drug companies and food companies, 26–27, 125–126 G research by, 108, 234–240 Galson",
      "133, rigor of its reviews and inspections",
      "scandals and politics"
    ],
    "type": "article-journal",
    "volume": [
      "297",
      "31",
      "31, 35",
      "60–61, 74–75, 113, inspections, 103–105, 123–124 150, 154–155, 181–182, 215, 269",
      "83, 127",
      "144–145, 162, 177, 220",
      "250, 280",
      "79",
      "126",
      "140, 148, 150, 155",
      "32, 69"
    ]
  },
  {
    "author": [
      {
        "family": "Act",
        "given": "F.D.A.Modernization"
      }
    ],
    "date": [
      "1997"
    ],
    "note": [
      "60, 88, 103, Geron Corporation, 294 152 Girand, Laurie, 191–194, 200 Federal Trade Commission (FTC), 66, 70 Golenski, John D., 187, 259, 261 Feigal, Dr. David W. Jr., 71–73, 103, 130–131, Goodman, Jesse, 144–145, 151, 226, 242, 244,"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Marcus",
        "given": "Dr Erin N."
      }
    ],
    "container-title": [
      "Irwin"
    ],
    "note": [
      "Department of Agriculture (USDA), 66–68, Marburger, Dr. John H.",
      "136, Drug Enforcement Administration (DEA), 148–149,",
      "70–71 Marti Nelson Foundation, 201 drugs, 70–71 Martin, Jack W., 54 eggs, 65–66 McClellan, Dr. Mark B., 62–63, 77, 106, 119, Environmental Protection Agency (EPA), 156, 165–166, 170, 212, 215–216, 220, INDEX 337"
    ],
    "pages": [
      "74–76",
      "128–129,",
      "185–186, 188–189"
    ],
    "title": [
      "264 devices, 71–72 Martin, Dr"
    ],
    "type": "article-journal",
    "volume": [
      "III, 222 70",
      "92, 126",
      "156, 162"
    ]
  },
  {
    "author": [
      {
        "family": "McGregor",
        "given": "Scott"
      },
      {
        "family": "Parkman",
        "given": "Dr Paul D."
      }
    ],
    "date": [
      "1976"
    ],
    "note": [
      "47, 57 Patent medicines, 36–39 Medical Devices User Fee Act (MDUFA) Pawlenty, Tim, 165"
    ],
    "title": [
      "191 investigational new drug application (IND), McLearn, Donald, 165–166 8, 82–84 Meat new drug application (NDA), 8, 96–108 agencies responsible for, 68",
      "234 meat processing industry, 166–167 Patent and Trademark Office, U.S., 280 Medical Devices Amendments"
    ],
    "type": "patent"
  },
  {
    "date": [
      "1997"
    ],
    "pages": [
      "265–266"
    ],
    "title": [
      "152 Paxil CR advertising"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Meyer",
        "given": "Dr Henry M.",
        "suffix": "Jr"
      }
    ],
    "container-title": [
      "Richard"
    ],
    "note": [
      "230–231 Meyer, Gerry, 30–31, 54, 56, 197, 211, 234, Peck, Dr. Carl C., 54, 59, 77, 86, 118, 120,"
    ],
    "pages": [
      "226–228,"
    ],
    "title": [
      "234 Pazdur, Dr"
    ],
    "type": "article-journal",
    "volume": [
      "93"
    ]
  },
  {
    "author": [
      {
        "given": "Paperwork"
      }
    ],
    "note": [
      "81–82 Relman, Arnold S., 277 essentially true horror stories, 94–96 Restaurants, 69–70, 167–168"
    ],
    "title": [
      "79–108, 133 Redux, deaths from, 61 clinical trials. See Clinical trials Regan, Barbara A., 101 drug development process"
    ],
    "type": null
  }
]
